Companion Animal Product & Promotions Guide

Terms and Conditions Cannot be combined with other offers. All BRAVECTO brand product and SENTINEL brand product SKUs are eligible and qualify for the BRAVECTO and SENTINEL brand products rebates. Promotion dates are January 16, 2023, through February 28, 2023 ("Promotion Period"). To qualify for "One-Brand Rebate," a qualifying clinic must purchase a minimum of 20 cartons of BRAVECTO brand products or 20 cartons of SENTINEL brand products cumulatively during the Promotion Period. To qualify for "Two-Brand Rebate," a minimum of 20 total cartons of BRAVECTO and SENTINEL brand products must be purchased cumulatively during the Promotion Period. Clinic must purchase at least one carton of BRAVECTO brand products and one carton of SENTINEL brand products to be eligible for the "Two-Brand Rebate." However, beyond this minimum requirement, the allocation of cartons between products from the two brands will not otherwise affect a clinic's eligibility to receive the "Two-Brand Rebate." In addition to the "One-Brand Rebate" and "Two-Brand Rebate," all qualifying purchases of SENTINEL brand products will receive an additional seven percent (7%) rebate. Qualifying purchase(s) must be ordered within the Promotion Period, and the complete order must be invoiced within 7 days of the end of the Promotion Period. Back-ordered products and returned products are not eligible. Clinic must pay full vet retail price on purchased BRAVECTO brand products and SENTINEL brand products to qualify for rebate. Offer valid only for veterinary clinics that have a valid Veterinary Patient Client Relationship, as defined by AVMA. Offer available to clinics in the 50 United States or the District of Columbia only. Allow 8–10 weeks for rebate processing (after end of the Promotion Period). Purchases count toward the Merck Animal Health (MAH) 2023 PerPETual Loyalty Program and 2023 OneMerck Loyalty Program where otherwise eligible pursuant to the terms of each program. Void where prohibited by law. MAH reserves the right to cancel or amend this program without notice at any time, for any reason, at its sole discretion. IMPORTANT SAFETY INFORMATION: BRAVECTO 1-MONTH (fluralaner) Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO (fluralaner topical solution) for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO (fluralaner topical solution) for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topication solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated. BRAVECTO Chews and Topical Solution for Dogs have not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for Dogs are not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for Cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS have not been established in breeding, pregnant and lactating cats. All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. SENTINEL® SPECTRUM® Chews (milbemycin oxime/lufenuron/praziquantel): Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For complete product information, refer to the product insert. SENTINEL® FLAVOR TABS® (milbemycin oxime/lufenuron): Dogs should be tested for heartworm prior to use. In a small percentage of treated dogs, digestive, neurologic, and skin side effects may occur. For complete product information, refer to the product insert. To place your order, contact your Merck Animal Health Representative, who will be happy to help you save. Copyright ©2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. US-BRV-221000011 Terms and Conditions Cannot be combined with other offers. All BRAVECTO brand product and SENTINEL brand product SKUs are eligible and qualify for the BRAVECTO and SENTINEL brand products rebates. Promotion dates are January 16, 2023, through February 28, 2023 ("Promotion Period"). To qualify for "One-Brand Rebate," a qualifying clinic must purchase a minimum of 20 cartons of BRAVECTO brand products or 20 cartons of SENTINEL brand products cumulatively during the Promotion Period. To qualify for "Two-Brand Rebate," a minimum of 20 total cartons of BRAVECTO and SENTINEL brand products must be purchased cumulatively during the Promotion Period. Clinic must purchase at least one carton of BRAVECTO brand products and one carton of SENTINEL brand products to be eligible for the "Two-Brand Rebate." However, beyond this minimum requirement, the allocation of cartons between products from the two brands will not otherwise affect a clinic's eligibility to receive the "Two-Brand Rebate." In addition to the "One-Brand Rebate" and "Two-Brand Rebate," all qualifying purchases of SENTINEL brand products will receive an additional seven percent (7%) rebate. Qualifying purchase(s) must be ordered within the Promotion Period, and the complete order must be invoiced within 7 days of the end of the Promotion Period. Back-ordered products and returned products are not eligible. Clinic must pay full vet retail price on purchased BRAVECTO brand products and SENTINEL brand products to qualify for rebate. Offer valid only for veterinary clinics that have a valid Veterinary Patient Client Relationship, as defined by AVMA. Offer available to clinics in the 50 United States or the District of Columbia only. Allow 8–10 weeks for rebate processing (after end of the Promotion Period). Purchases count toward the Merck Animal Health (MAH) 2023 PerPETual Loyalty Program and 2023 OneMerck Loyalty Program where otherwise eligible pursuant to the terms of each program. Void where prohibited by law. MAH reserves the right to cancel or amend this program without notice at any time, for any reason, at its sole discretion. IMPORTANT SAFETY INFORMATION: BRAVECTO 1-MONTH (fluralaner) Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO (fluralaner topical solution) for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO (fluralaner topical solution) for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topication solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated. BRAVECTO Chews and Topical Solution for Dogs have not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for Dogs are not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for Cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS have not been established in breeding, pregnant and lactating cats. All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. SENTINEL® SPECTRUM® Chews (milbemycin oxime/lufenuron/praziquantel): Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For complete product information, refer to the product insert. SENTINEL® FLAVOR TABS® (milbemycin oxime/lufenuron): Dogs should be tested for heartworm prior to use. In a small percentage of treated dogs, digestive, neurologic, and skin side effects may occur. For complete product information, refer to the product insert. To place your order, contact your Merck Animal Health Representative, who will be happy to help you save. Copyright ©2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. US-BRV-221000011 Terms and Conditions Cannot be combined with other offers. All BRAVECTO brand product and SENTINEL brand product SKUs are eligible and qualify for the BRAVECTO and SENTINEL brand products rebates. Promotion dates are January 16, 2023, through February 28, 2023 ("Promotion Period"). To qualify for "One-Brand Rebate," a qualifying clinic must purchase a minimum of 20 cartons of BRAVECTO brand products or 20 cartons of SENTINEL brand products cumulatively during the Promotion Period. To qualify for "Two-Brand Rebate," a minimum of 20 total cartons of BRAVECTO and SENTINEL brand products must be purchased cumulatively during the Promotion Period. Clinic must purchase at least one carton of BRAVECTO brand products and one carton of SENTINEL brand products to be eligible for the "Two-Brand Rebate." However, beyond this minimum requirement, the allocation of cartons between products from the two brands will not otherwise affect a clinic's eligibility to receive the "Two-Brand Rebate." In addition to the "One-Brand Rebate" and "Two-Brand Rebate," all qualifying purchases of SENTINEL brand products will receive an additional seven percent (7%) rebate. Qualifying purchase(s) must be ordered within the Promotion Period, and the complete order must be invoiced within 7 days of the end of the Promotion Period. Back-ordered products and returned products are not eligible. Clinic must pay full vet retail price on purchased BRAVECTO brand products and SENTINEL brand products to qualify for rebate. Offer valid only for veterinary clinics that have a valid Veterinary Patient Client Relationship, as defined by AVMA. Offer available to clinics in the 50 United States or the District of Columbia only. Allow 8–10 weeks for rebate processing (after end of the Promotion Period). Purchases count toward the Merck Animal Health (MAH) 2023 PerPETual Loyalty Program and 2023 OneMerck Loyalty Program where otherwise eligible pursuant to the terms of each program. Void where prohibited by law. MAH reserves the right to cancel or amend this program without notice at any time, for any reason, at its sole discretion. IMPORTANT SAFETY INFORMATION: BRAVECTO 1-MONTH (fluralaner) Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO (fluralaner topical solution) for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO (fluralaner topical solution) for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topication solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated. BRAVECTO Chews and Topical Solution for Dogs have not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for Dogs are not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for Cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS have not been established in breeding, pregnant and lactating cats. All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. SENTINEL® SPECTRUM® Chews (milbemycin oxime/lufenuron/praziquantel): Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For complete product information, refer to the product insert. SENTINEL® FLAVOR TABS® (milbemycin oxime/lufenuron): Dogs should be tested for heartworm prior to use. In a small percentage of treated dogs, digestive, neurologic, and skin side effects may occur. For complete product information, refer to the product insert. To place your order, contact your Merck Animal Health Representative, who will be happy to help you save. Copyright ©2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. US-BRV-221000011 Terms and Conditions Cannot be combined with other offers. All BRAVECTO brand product and SENTINEL brand product SKUs are eligible and qualify for the BRAVECTO and SENTINEL brand products rebates. Promotion dates are January 16, 2023, through February 28, 2023 ("Promotion Period"). To qualify for "One-Brand Rebate," a qualifying clinic must purchase a minimum of 20 cartons of BRAVECTO brand products or 20 cartons of SENTINEL brand products cumulatively during the Promotion Period. To qualify for "Two-Brand Rebate," a minimum of 20 total cartons of BRAVECTO and SENTINEL brand products must be purchased cumulatively during the Promotion Period. Clinic must purchase at least one carton of BRAVECTO brand products and one carton of SENTINEL brand products to be eligible for the "Two-Brand Rebate." However, beyond this minimum requirement, the allocation of cartons between products from the two brands will not otherwise affect a clinic's eligibility to receive the "Two-Brand Rebate." In addition to the "One-Brand Rebate" and "Two-Brand Rebate," all qualifying purchases of SENTINEL brand products will receive an additional seven percent (7%) rebate. Qualifying purchase(s) must be ordered within the Promotion Period, and the complete order must be invoiced within 7 days of the end of the Promotion Period. Back-ordered products and returned products are not eligible. Clinic must pay full vet retail price on purchased BRAVECTO brand products and SENTINEL brand products to qualify for rebate. Offer valid only for veterinary clinics that have a valid Veterinary Patient Client Relationship, as defined by AVMA. Offer available to clinics in the 50 United States or the District of Columbia only. Allow 8–10 weeks for rebate processing (after end of the Promotion Period). Purchases count toward the Merck Animal Health (MAH) 2023 PerPETual Loyalty Program and 2023 OneMerck Loyalty Program where otherwise eligible pursuant to the terms of each program. Void where prohibited by law. MAH reserves the right to cancel or amend this program without notice at any time, for any reason, at its sole discretion. IMPORTANT SAFETY INFORMATION: BRAVECTO 1-MONTH (fluralaner) Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO (fluralaner topical solution) for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO (fluralaner topical solution) for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topication solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated. BRAVECTO Chews and Topical Solution for Dogs have not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for Dogs are not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for Cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS have not been established in breeding, pregnant and lactating cats. All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. SENTINEL® SPECTRUM® Chews (milbemycin oxime/lufenuron/praziquantel): Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For complete product information, refer to the product insert. SENTINEL® FLAVOR TABS® (milbemycin oxime/lufenuron): Dogs should be tested for heartworm prior to use. In a small percentage of treated dogs, digestive, neurologic, and skin side effects may occur. For complete product information, refer to the product insert. To place your order, contact your Merck Animal Health Representative, who will be happy to help you save. Copyright ©2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. US-BRV-221000011 Terms and Conditions Cannot be combined with other offers. All BRAVECTO brand product and SENTINEL brand product SKUs are eligible and qualify for the BRAVECTO and SENTINEL brand products rebates. Promotion dates are January 16, 2023, through February 28, 2023 ("Promotion Period"). To qualify for "One-Brand Rebate," a qualifying clinic must purchase a minimum of 20 cartons of BRAVECTO brand products or 20 cartons of SENTINEL brand products cumulatively during the Promotion Period. To qualify for "Two-Brand Rebate," a minimum of 20 total cartons of BRAVECTO and SENTINEL brand products must be purchased cumulatively during the Promotion Period. Clinic must purchase at least one carton of BRAVECTO brand products and one carton of SENTINEL brand products to be eligible for the "Two-Brand Rebate." However, beyond this minimum requirement, the allocation of cartons between products from the two brands will not otherwise affect a clinic's eligibility to receive the "Two-Brand Rebate." In addition to the "One-Brand Rebate" and "Two-Brand Rebate," all qualifying purchases of SENTINEL brand products will receive an additional seven percent (7%) rebate. Qualifying purchase(s) must be ordered within the Promotion Period, and the complete order must be invoiced within 7 days of the end of the Promotion Period. Back-ordered products and returned products are not eligible. Clinic must pay full vet retail price on purchased BRAVECTO brand products and SENTINEL brand products to qualify for rebate. Offer valid only for veterinary clinics that have a valid Veterinary Patient Client Relationship, as defined by AVMA. Offer available to clinics in the 50 United States or the District of Columbia only. Allow 8–10 weeks for rebate processing (after end of the Promotion Period). Purchases count toward the Merck Animal Health (MAH) 2023 PerPETual Loyalty Program and 2023 OneMerck Loyalty Program where otherwise eligible pursuant to the terms of each program. Void where prohibited by law. MAH reserves the right to cancel or amend this program without notice at any time, for any reason, at its sole discretion. IMPORTANT SAFETY INFORMATION: BRAVECTO 1-MONTH (fluralaner) Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO (fluralaner topical solution) for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO (fluralaner topical solution) for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topication solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated. BRAVECTO Chews and Topical Solution for Dogs have not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for Dogs are not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for Cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS have not been established in breeding, pregnant and lactating cats. All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. SENTINEL® SPECTRUM® Chews (milbemycin oxime/lufenuron/praziquantel): Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For complete product information, refer to the product insert. SENTINEL® FLAVOR TABS® (milbemycin oxime/lufenuron): Dogs should be tested for heartworm prior to use. In a small percentage of treated dogs, digestive, neurologic, and skin side effects may occur. For complete product information, refer to the product insert. To place your order, contact your Merck Animal Health Representative, who will be happy to help you save. Copyright ©2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. US-BRV-221000011 Terms and Conditions Cannot be combined with other offers. All BRAVECTO brand product and SENTINEL brand product SKUs are eligible and qualify for the BRAVECTO and SENTINEL brand products rebates. Promotion dates are January 16, 2023, through February 28, 2023 ("Promotion Period"). To qualify for "One-Brand Rebate," a qualifying clinic must purchase a minimum of 20 cartons of BRAVECTO brand products or 20 cartons of SENTINEL brand products cumulatively during the Promotion Period. To qualify for "Two-Brand Rebate," a minimum of 20 total cartons of BRAVECTO and SENTINEL brand products must be purchased cumulatively during the Promotion Period. Clinic must purchase at least one carton of BRAVECTO brand products and one carton of SENTINEL brand products to be eligible for the "Two-Brand Rebate." However, beyond this minimum requirement, the allocation of cartons between products from the two brands will not otherwise affect a clinic's eligibility to receive the "Two-Brand Rebate." In addition to the "One-Brand Rebate" and "Two-Brand Rebate," all qualifying purchases of SENTINEL brand products will receive an additional seven percent (7%) rebate. Qualifying purchase(s) must be ordered within the Promotion Period, and the complete order must be invoiced within 7 days of the end of the Promotion Period. Back-ordered products and returned products are not eligible. Clinic must pay full vet retail price on purchased BRAVECTO brand products and SENTINEL brand products to qualify for rebate. Offer valid only for veterinary clinics that have a valid Veterinary Patient Client Relationship, as defined by AVMA. Offer available to clinics in the 50 United States or the District of Columbia only. Allow 8–10 weeks for rebate processing (after end of the Promotion Period). Purchases count toward the Merck Animal Health (MAH) 2023 PerPETual Loyalty Program and 2023 OneMerck Loyalty Program where otherwise eligible pursuant to the terms of each program. Void where prohibited by law. MAH reserves the right to cancel or amend this program without notice at any time, for any reason, at its sole discretion. IMPORTANT SAFETY INFORMATION: BRAVECTO 1-MONTH (fluralaner) Chews: indicated for dogs 8 weeks of age and older. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. BRAVECTO 1-MONTH is not effective against A. americanum in puppies less than 6 months of age. BRAVECTO (fluralaner) Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. BRAVECTO (fluralaner topical solution) for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. BRAVECTO (fluralaner topical solution) for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topication solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated. BRAVECTO Chews and Topical Solution for Dogs have not been shown to be effective for 12-weeks' duration in puppies or kittens less than 6 months of age. BRAVECTO Chews and Topical Solution for Dogs are not effective against the lone star tick beyond 8 weeks of dosing. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for Cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS have not been established in breeding, pregnant and lactating cats. All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. Use with caution in dogs with a history of seizures or neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. SENTINEL® SPECTRUM® Chews (milbemycin oxime/lufenuron/praziquantel): Dogs should be tested for heartworm prior to use. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. For complete product information, refer to the product insert. SENTINEL® FLAVOR TABS® (milbemycin oxime/lufenuron): Dogs should be tested for heartworm prior to use. In a small percentage of treated dogs, digestive, neurologic, and skin side effects may occur. For complete product information, refer to the product insert. To place your order, contact your Merck Animal Health Representative, who will be happy to help you save. Copyright ©2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved. US-BRV-221000011

• Cover